Lu Jiayue, Zhu Minxia, Liu Shang, Zhu Mingli, Pang Huihua, Lin Xinghui, Ni Zhaohui, Qian Jiaqi, Cai Hong, Zhang Weiming
a Department of Nephrology, South Campus, Renji Hospital, School of Medicine , Shanghai Jiao Tong University , Shanghai , China.
b Department of Nephrology, Renji Hospital, School of Medicine , Shanghai Jiao Tong University , Shanghai , China.
Ren Fail. 2017 Nov;39(1):417-422. doi: 10.1080/0886022X.2017.1305407.
The objective of this study is to investigate the relationship between blood pressure changes and all-cause mortality, and between blood pressure changes and cardiovascular mortality, for maintenance hemodialysis (MHD) patients during dialysis.
Data regarding general condition, biochemical indices, and survival prognosis of MHD patients who were treated at the Shanghai Jiao Tong University School of Medicine-affiliated Renji Hospital from July 2007 to December 2012 were collected, in order to evaluate the relationship between patients' blood pressure changes during hemodialysis and mortality.
Among 364 patients, with an average age of 63.07 ± 13.93 years, an average dialysis vintage of 76.00 (range, 42.25-134.00) months, and a follow-up time of 54.86 ± 19.84 months, there were 85 cases (23.4%) of all-cause death and 46 cases (14.2%) of cardiovascular death. All-cause mortality and cardiovascular mortality were lowest (OR, 0.324 and 0.335; 95% CI, 0.152-0.692 and 0.123-0.911; p value, .004 and .032, respectively) in patients whose systolic blood pressure difference (ΔSBP) before and after dialysis was between 7.09 and 14.25 mmHg. Kaplan-Meier analysis indicated that both all-cause mortality and cardiovascular mortality were markedly increased for patients with ΔSBPless than -0.25 mmHg (p value, .001 and .044, respectively). Cox regression analysis showed that ΔSBP< -0.25 mmHg, hemoglobin concentration, Kt/v and albumin were independent risk factors for all-cause mortality in MHD patients.
MHD patients whose blood pressure increased significantly after hemodialysis had a higher risk of dying; ΔSBP, hemoglobin concentration, Kt/v and albumin were independent risk factors for all-cause mortality in MHD patients.
本研究旨在探讨维持性血液透析(MHD)患者透析期间血压变化与全因死亡率之间以及血压变化与心血管死亡率之间的关系。
收集2007年7月至2012年12月在上海交通大学医学院附属仁济医院接受治疗的MHD患者的一般情况、生化指标和生存预后数据,以评估患者透析期间血压变化与死亡率之间的关系。
在364例患者中,平均年龄为63.07±13.93岁,平均透析龄为76.00(范围42.25 - 134.00)个月,随访时间为54.86±19.84个月,全因死亡85例(23.4%),心血管死亡46例(14.2%)。透析前后收缩压差值(ΔSBP)在7.09至14.25 mmHg之间的患者全因死亡率和心血管死亡率最低(OR分别为0.324和0.335;95%CI分别为0.152 - 0.692和0.123 - 0.911;p值分别为0.004和0.032)。Kaplan-Meier分析表明,ΔSBP小于-0.25 mmHg的患者全因死亡率和心血管死亡率均显著增加(p值分别为0.001和0.044)。Cox回归分析显示,ΔSBP < -0.25 mmHg、血红蛋白浓度、Kt/v和白蛋白是MHD患者全因死亡的独立危险因素。
血液透析后血压显著升高的MHD患者死亡风险更高;ΔSBP、血红蛋白浓度、Kt/v和白蛋白是MHD患者全因死亡的独立危险因素。